Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling

Journal of Controlled Release

Volumn 149, Issue 2, 2011, Pages 175-181

  Ali, Hany S M ^a,b   York, Peter ^a   Ali, Ahmed M A ^c   Blagden, Nicholas ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b Assiut University   (Egypt)

^c Beni Suef University   (Egypt)

Author keywords

Controlled release; Hydrocortisone; Microfluidics; Milling; Nanosuspension; Ophthalmic delivery

Indexed keywords

CONTROLLED RELEASE; HYDROCORTISONE; MILLING; NANO-SUSPENSIONS; OPHTHALMIC DELIVERY;

BIOCHEMISTRY; CAPILLARY FLOW; DIFFERENTIAL SCANNING CALORIMETRY; MILLING (MACHINING); PARTICLE SIZE; PRECIPITATION (CHEMICAL); X RAY DIFFRACTION; ZETA POTENTIAL;

MICROFLUIDICS;

HYDROCORTISONE;

ARTICLE; COMPARATIVE STUDY; CRYSTAL STRUCTURE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; INTRAOCULAR DRUG ADMINISTRATION; MICROFLUIDIC NANOPRECIPITATION; MICROFLUIDICS; NANOSUSPENSION; NANOTECHNOLOGY; PARTICLE SIZE; PRIORITY JOURNAL; RABBIT; SUSTAINED DRUG RELEASE; WET MILLING; ZETA POTENTIAL;

ANIMALS; BIOLOGICAL AVAILABILITY; CHEMICAL PRECIPITATION; DRUG CARRIERS; DRUG COMPOUNDING; EYE; HYDROCORTISONE; MALE; MICROFLUIDICS; NANOSTRUCTURES; NANOTECHNOLOGY; OPHTHALMIC SOLUTIONS; PARTICLE SIZE; RABBITS; SOLUTIONS; SUSPENSIONS; WETTABILITY;

EID: 78651356705     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.10.007     Document Type: Article

References (40)

1. F. Kesisoglou, S. Panmai, and Y. Wu Nanosizing-oral formulation development and biopharmaceutical evaluation Adv. Drug Deliv. Rev. 59 2007 631 644
2. S. Ganta, J.W. Paxton, B.C. Baguley, and S. Garg Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery Int. J. Pharm. 367 1-2 2009 179 186
3. J. Hecq, M. Deleers, D. Fanara, H. Vranckx, P. Boulanger, S. Le Lamer, and K. Amighi Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base Eur. J. Pharm. Biopharm. 64 3 2006 360 368
4. W. Yang, J. Tam, D.A. Miller, J. Zhou, J.T. McConville, K.P. Johnston, and R.O. Williams Iii High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers Int. J. Pharm. 361 1-2 2008 177 188
5. B.E. Rabinow Nanosuspensions in drug delivery Nat. Rev. Drug Discov. 3 9 2004 785 796
6. X.S. Li, J.X. Wang, Z.G. Shen, P.Y. Zhang, J.F. Chen, and J. Yun Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method Int. J. Pharm. 342 1-2 2007 26 32
7. Y. He, Y. Huang, and Y. Cheng Structure evolution of curcumin nanoprecipitation from a micromixer Cryst. Growth Des. 10 3 2010 1021 1024
8. H. Zhao, J.X. Wang, Q.A. Wang, J.F. Chen, and J. Yun Controlled liquid antisolvent precipitation of hydrophobic pharmaceutical nanoparticles in a microchannel reactor Ind. Eng. Chem. Res. 46 24 2007 8229 8235
9. H.X. Zhang, J.X. Wang, L. Shao, and J.F. Chen Microfluidic fabrication of monodispersed pharmaceutical colloidal spheres of atorvastatin calcium with tunable sizes Ind. Eng. Chem. Res. 49 9 2010 4156 4161
10. R. Karnik, F. Gu, P. Basto, C. Cannizzaro, L. Dean, W. Kyei-Manu, R. Langer, and O.C. Farokhzad Microfluidic platform for controlled synthesis of polymeric nanoparticles Nano Lett. 8 9 2008 2906 2912
11. R.C. Nagarwal, S. Kant, P.N. Singh, P. Maiti, and J.K. Pandit Polymeric nanoparticulate system: a potential approach for ocular drug delivery J. Control Rel. 136 1 2009 2 13
12. H. Gupta, M. Aqil, R.K. Khar, A. Ali, A. Bhatnagar, and G. Mittal Sparfloxacin loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine: Nanotechnology Biology and Medicine 6 22 2010 324 333
13. O. Séchoy, G. Tissié, C. Sébastian, F. Maurin, J.-Y. Driot, and C. Trinquand A new long acting ophthalmic formulation of carteolol containing alginic acid Int. J. Pharm. 207 1-2 2000 109 116
14. J. Araújo, E. Gonzalez, M.A. Egea, M.L. Garcia, and E.B. Souto Nanomedicines for ocular NSAIDs: safety on drug delivery Nanomed. Nanotechnol. Biol. Med. 5 4 2009 394 401
15. S.K. Sahoo, F. Dilnawaz, and S. Krishnakumar Nanotechnology in ocular drug delivery Drug Discov. Today 13 3-4 2008 144 151
16. R. Pignatello, C. Bucolo, G. Spedalieri, A. Maltese, and G. Puglisi Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application Biomaterials 23 15 2002 3247 3255
17. N.M. Davies, G. Wang, and I.G. Tucker Evaluation of a hydrocortisone/hydroxypropyl-[beta]-cyclodextrin solution for ocular drug delivery Int. J. Pharm. 156 2 1997 201 209
18. A.R. Bary, I.G. Tucker, and N.M. Davies Considerations in the use of hydroxypropyl-[beta]-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone Eur. J. Pharm. Biopharm. 50 2 2000 237 244
19. H.S.M. Ali, P. York, and N. Blagden Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors Int. J. Pharm. 375 1-2 2009 107 113
20. B.H. Weigl, R.L. Bardell, and C.R. Cabrera Lab-on-a-chip for drug development Adv. Drug Deliv. Rev. 55 3 2003 349 377
21. H.S.M. Ali, N. Blagden, P. York, A. Amani, and T. Brook Artificial neural networks modelling the prednisolone nanoprecipitation in microfluidic reactors Eur. J. Pharm. Sci. 37 3-4 2009 514 522
22. V.B. Patravale, A.A. Date, and R.M. Kulkarni Nanosuspensions: a promising drug delivery strategy J. Pharm. Pharmacol. 56 7 2004 827 840
23. E. Merisko-Liversidge, G.G. Liversidge, and E.R. Cooper Nanosizing: a formulation approach for poorly-water-soluble compounds Eur. J. Pharm. Sci. 18 2 2003 113 120
24. S. Kamiya, T. Kurita, A. Miyagishima, and M. Arakawa Preparation of griseofulvin nanoparticle suspension by high-pressure homogenization and preservation of the suspension with saccharides and sugar alcohols Drug Dev. Ind. Pharm. 35 8 2009 1022 1028
25. Z. Deng, S. Xu, and S. Li Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications Int. J. Pharm. 351 1-2 2008 236 243
26. D. Xia, P. Quan, H. Piao, H. Piao, S. Sun, Y. Yin, and F. Cui Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability Eur. J. Pharm. Sci. 40 4 2010 325 334
27. H. Steckel, N. Rasenack, P. Villax, and B.W. Müller In vitro characterization of jet-milled and in-situ-micronized fluticasone-17-propionate Int. J. Pharm. 258 1-2 2003 65 75
28. W. Yang, K.P. Johnston, and R.O. Williams Iii Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats Eur. J. Pharm. Biopharm. 75 1 2010 33 41
29. T. Niwa, Y. Nakanishi, and K. Danjo One-step preparation of pharmaceutical nanocrystals using ultra cryo-milling technique in liquid nitrogen Eur. J. Pharm. Sci. 41 1 2010 78 85
30. I. Opatowsky, R.M. Feldman, R. Gross, and S.T. Feldman Intraocular pressure elevation associated with inhalation and nasal corticosteroids Ophthalmology 102 2 1995 177 179
31. S.K. Law, and D.A. Lee Ocular pharmacology in glaucoma medical therapy: principles and management 2008 Oxford University Press USA, New York
32. R. Buggage Uveitic glaucoma D.J. Rhee, Glaucoma: color atlas and synopsis of clinical ophthalmolog 2003 The McGraw Hill companies USA 257 258
33. S.M. Safwat, M.A. Kassem, M.A. Attia, and M. Elmahdy The formulation-performance relationship of multiple emulsions and ocular activity J. Control. Release 32 3 1994 259 268
34. M.A. Kassem, A.A. Abdel Rahman, M.M. Ghorab, M.B. Ahmed, and R.M. Khalil Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs Int. J. Pharm. 340 1-2 2007 126 133
35. M.A. Kassem, M.A. Attia, S.M. Safwat, and M. Elmahdy Preparation and evaluation of hydrocortisone multiple emulsions in rabbits eye Pharm. Indus. 56 6 1994 584 588
36. R. Ravichandran Nanoparticles in drug delivery: potential green nanobiomedicine applications Int. J. Green Nanotechnol. Biomed. 1 2 2009 B108 B130
37. B. Van Eerdenbrugh, G. Van den Mooter, and P. Augustijns Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products Int. J. Pharm. 364 1 2008 64 75
38. S. Verma, R. Gokhale, and D.J. Burgess A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions Int. J. Pharm. 380 1-2 2009 216 222
39. J. Junghanns, and R.H. Muller Nanocrystal technology, drug delivery and clinical applications Int. J. Nanomed. 3 3 2008 295 309
40. L. Lindfors, P. Skantze, U. Skantze, J. Westergren, and U. Olsson Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth Langmuir 23 19 2007 9866 9874